陳明怡

Ms. Chen has over four years of venture capital related industry experience. She is currently focused on ITIC’s biomedical practice and is primarily responsible for strategic planning, investment analysis, and other investment operations in the biomedical industry. She also participates in fund raising activities.

Prior to joining ITIC, Ms. Chen specialized in investment evaluation, portfolio management and coordinated cross-border partnerships for Cheng Xin Technology Development Corp. and FAT Capital Management. She has also managed and exited several venture capital investments in the life science sector with exceptional returns.

Ms. Chen received a B.S. from National Taiwan University, an M.S. from Cornell University and an M.A. from Columbia University.